ADDING MULTIMEDIA Luminar and Mercedes-Benz Expands Partnership; Luminar Debuts New Emergency Steering AI Software with Iris+ and NVIDIA DRIVE Orin
Unveiled a concept of the Official FIA F1® Safety Car equipped with Luminar technology as an extension of existing work with Mercedes-Benz for their production... Read more.
Bridgewater Bancshares, Inc. to Announce Fourth Quarter 2023 Financial Results and Host Earnings Conference Call
ST. LOUIS PARK, Minn.–(BUSINESS WIRE)–Bridgewater Bancshares, Inc. (Nasdaq: BWB), the parent company of Bridgewater Bank, today announced that it will... Read more.
CORRECTING and REPLACING CES 2024: Intel Delivers New High-Level Compute Solutions in Mobile, Desktop and Edge
New Intel Core HX and U-series mobile processors bring robust Intel Core platform to new enthusiast and mainstream mobile systems, alongside expanded desktop stack... Read more.
Campaign US to Host Inaugural Conference on Creativity and Technology
NEW YORK–(BUSINESS WIRE)–Campaign US, a trailblazing force in the world of advertising and marketing news, is selling tickets for its inaugural conference,... Read more.
Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye
AR-15512, a topical transient receptor potential melastatin 8 (TRPM8) agonist, is a first-in-class product candidate for the treatment of the signs and symptoms... Read more.
Green Plains Inc. Completes Acquisition of Green Plains Partners LP
OMAHA, Neb.–(BUSINESS WIRE)–Green Plains Inc. (NASDAQ: GPRE) (“Green Plains”) and Green Plains Partners LP (NASDAQ: GPP) (the “Partnership”)... Read more.
Valaris Announces Contract Awards and Fleet Status Updates
HAMILTON, Bermuda–(BUSINESS WIRE)–Valaris Limited (NYSE: VAL) (“Valaris” or the “Company”) announced today new contracts and contract extensions,... Read more.
Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye
AR-15512, a topical transient receptor potential melastatin 8 (TRPM8) agonist, is a first-in-class product candidate for the treatment of the signs and symptoms... Read more.
KBRA Assigns Rating to Sixth Street Specialty Lending, Inc.’s $350 Million Senior Unsecured Notes Due 2029
NEW YORK–(BUSINESS WIRE)–#creditratingagency–KBRA assigns a rating of BBB+ to Sixth Street Specialty Lending, Inc.’s (NYSE: TSLX or “the company”)... Read more.
Q1 2024 Insurance Labor Market Study Now Open for Participation
CHICAGO–(BUSINESS WIRE)–#HiringTrends–The first-quarter 2024 iteration of the Semi-Annual U.S. Insurance Labor Market Study, conducted by The Jacobson... Read more.